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Abstract
NanoESI-MS is used for determining binding strengths of trypsin in complex with two different
series of five congeneric inhibitors, whose binding affinity in solution depends on the size of the
P3 substituent. The ligands of the first series contain a 4-amidinobenzylamide as P1 residue,
and form a tight complex with trypsin. The inhibitors of the second series have a 2-aminomethyl-
5-chloro-benzylamide as P1 group, and represent a model system for weak binders. The five
different inhibitors of each group are based on the same scaffold and differ only in the length of
the hydrophobic side chain of their P3 residue, which modulates the interactions in the S3/4
binding pocket of trypsin. The dissociation constants (KD) for high affinity ligands investigated by
nanoESI-MS ranges from 15 nM to 450 nM and decreases with larger hydrophobic P3 side
chains. Collision-induced dissociation (CID) experiments of five trypsin and benzamidine-based
complexes show a correlation between trends in KD and gas-phase stability. For the second
inhibitor series we could show that the effect of imidazole, a small stabilizing additive, can avoid
the dissociation of the complex ions and as a result increases the relative abundance of weakly
bound complexes. Here the KD values ranging from 2.9 to 17.6 μM, some 1–2 orders of
magnitude lower than the first series. For both ligand series, the dissociation constants (KD)
measured via nanoESI-MS were compared with kinetic inhibition constants (Ki) in solution.
Key words: Noncovalent interactions, Electrospray ionization mass spectrometry, Binding
affinity, Trypsin, Protein–ligand complexes, Hydrophobic effect
Introduction
Electrospray ionization mass spectrometry (ESI-MS) is apowerful and increasingly utilized tool for the investi-
gation of noncovalent interactions [1]. This soft ionization
technique allows the transfer of noncovalent complexes from
solution into the gas phase and their subsequent study by mass
spectrometry. To this day, protein–protein, protein–small
molecule, protein–DNA, and DNA–small molecule complexes
have been successfully detected and studied by this method
[2–4]. Especially in drug discovery ESI-MS is of increasing
importance for the investigation of protein-ligand interactions
and determination of binding affinities [5, 6]. In recent years,
binding affinities (KD) have been successfully determined by
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ESI-MS for a variety of noncovalent protein-ligand complexes
[2, 7, 8]. Other MS-based methods have also been successfully
applied for quantifying interactions (e.g., methods dubbed
“protein–ligand interactions in solution by MS, titration and
H/D exchange” (PLIMSTEX) and “stability of unpurified
proteins from rates of H/D exchange” (SUPREX) [9–11].
Noncovalent interactions are of great importance in nature;
for example they play a major role in stabilizing protein
conformation. The hydrophobic effect plays an important role
in protein folding, in the adhesion of lipid bilayers, nucleic acid
structures, and protein-small molecule interactions [12–14].
Compared with the aqueous environment, the hydration shell is
absent in the gas phase, and its not yet fully clear whether the
conformation of noncovalent complexes remains unchanged
during the transition from solution to vacuum [15]. Some
forces such as hydrogen-bonding and electrostatic interactions
between two oppositely charged molecules are strengthened in
the gas phase, while hydrophobic interactions are weakened
and therefore difficult to preserve during ionization and ion
transfer [16, 17]. A number of research groups have reported
investigations of noncovalent complexes where hydrophobic
interactions play a dominant role for the complex stability [18–
20]. In a very recent study, Klassen and co-workers [21, 22]
demonstrated the application of ESI-MS to quantify binding
strengths of β-lactoglobulin - fatty acid complexes in aqueous
solution. For three short fatty acids, association constants
smaller than expected were found by the authors (Ka compared
with data from a competitive fluorescence assay). They
explained this with an in-source dissociation, which reduces
the relative abundance of gaseous complex ions measured by
ESI-MS. In a previous study of the same research group it was
shown that β-lactoglobulin retains the structure of its binding
cavity even in the absence of a hydration shell [23]. The authors
monitored the dissociation of the fatty acid-protein complexes
in a BIRD experiment and extracted the temperature-dependent
kinetic parameters. Their results show that the energy required
for dissociation correlates with the length of the hydrocarbon
fatty acid chain. Surprisingly, quantitative comparison of the
dissociation rate constants in the hydrated and dehydrated
states showed that the solvated complex is kinetically less
stable than the corresponding gaseous ions at all temperature
investigated [24].
Even when carefully controlling the instrument parameters,
complexes that are predominatly stabilized by nonpolar
interactions are prone to dissociation in the gas phase [25].
This so-called in-source dissociation can lead to an artificially
low binding constants based on the reduced abundance of the
complex ions [21]. Stabilization by addition of imidazole to the
nanoES solution was presented as a solution for this problem
for several weakly bound complexes [26, 27]. The small
imidazole molecule acts as a nonspecific, sacrificial ligand and
can prevent dissociation of the specifically bound ligand during
ES-MS analysis. This can also be thought of as enhanced
evaporative cooling of the protein-ligand complex ions in the
ion source. The extent of the stabilization depends strongly on
the concentration of imidazole. At high imidazole concen-
trations (91 mM), the ions of protein-fatty acid, protein-
carbohydrate and protein-small molecule complexes can be
stabilized [26], although it is not always possible to prevent
dissociation of very labile gas-phase complexes, [26, 28, 29].
To determine binding constants, we used the ES-MS
titration method, which has been found suitable for measuring
binding strengths, not only in our laboratory but also in other
groups [2, 18, 30–32]. It has also been validated against more
established biophysical methods, such as isothermal titration
calorimetry (ITC), surface plasmon resonance (SPR), and
nuclear magnetic resonance (NMR) spectroscopy [32–36].
The well-described titration method relies on detection of ions
belonging to the complex versus bare proteins. The KD value
can then be easily determined from a fit of the intensity ratio of
bound and unbound protein as a function of the added ligand.
This method assumes that no dissociation takes place during
the transmission through the mass spectrometer. The second
important assumption is that the intensity ratio observed in the
gas phase correlates with the concentration ratio in solution. If a
very low-mass ligand is bound to a high-mass protein, the
ionization efficiency does not change for the complex vs. the
bare protein, and this assumption is fulfilled in almost all cases
[2]. As the ESI titration measurements can deliver a “snapshot”
of the solution concentrations the KD values determined via
nanoESI-MS reflect solution-phase binding affinities.
In this work, we present a systematic nanoESI-MS study for
quantifying the binding strengths of trypsin in complex with
two different series of competitive inhibitor. Closely related 4-
amidinobenzylamide- (AMBA) and 2-aminomethyl-5-chlor-
benzylamide-based (CMA) inhibitors were chosen to gauge
how their hydrophobic side chains modulate the interaction
(Table 1). The two different types of inhibitors are based on the
same scaffold and each series varies only in the length of the
hydrophobic P3 side chain. In essence, we expected that the
binding affinity should increase with increasing length of the
hydrophobic chain that is accommodated by the predominantly
hydrophobic S3/4 cavity of the enzyme. We are using two
compound model systems: benzamidine-type ligands that
exhibit strong binding affinity to trypsin, while the CMA-
based ligands show lower. The protein used in this study,
bovine α-trypsin, belongs to the family of the well-known
serine proteases. Compounds that specifically inhibit these
serine proteases can be used for the treatment of different
diseases. For example, in the last years the first orally available
thrombin and factor Xa inhibitors were approved as anti-
coagulants [35, 36].
The basic question is whether we can observe the expected
trend in the binding affinity of the inhibitors, when using ESI-
MS as a read-out for the solution phase equilibrium. In the case
of the benzamidine-based ligands, the binding affinity based on
ESI titration measurements increases with increasing length of
the hydrophobic P3 side chain, from 15 to 450 nM. A second
question concerns the stability in solution vs. in the gas phase.
In some studies it was shown that the gas-phase stability
reflects the binding properties in solution [37–39]. More
frequently, however, a correlation between the gas-phase
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stability and the solution-phase stability is absent [25, 26, 28,
40–46], for example for leucine-zippers and acyl-CoA binding
protein (ACBP) and a series of acyl CoA derivatives [28]. If
binding properties in solution correlate with gas-phase stability
it has to be assumed that the dominant interactions are very
similar in solution and in the gas phase, and that solvent
mediation play only a minor role (see Daniel at al. and Sharon
and Robinson for comprehensive reviews on this topic [2, 46]).
In our study the CID experiments for the benzamidine
complexes show a correlation between the binding affinities
in solution and the gas phase stability.
The complexes with the CMA inhibitors were prone to
in-source dissociation. The main reason may be that
complexes stabilized in solution by weak nonpolar inter-
actions exhibit low gas-phase stability [27]. Therefore we
have investigated the stabilizing effect of imidazole on this
particular model system. Like Klassen and co-workers [21,
22] we found that the addition of imidazole to the nanoESI
solution can protect protein-ligand complexes from in-source
dissociation during the ESI-MS analysis process. Unlike in
the case of the benzamidine series, the trend of higher
binding affinity is clearly observed, with the order Gly G D-
Ala G D-Leu. No independently measured KDs are available
for these systems. Therefore, binding affinities determined
by MS were compared with inhibition constants (Ki)
determined via an enzyme kinetic inhibition assay.
Experimental
Materials and Methods
Bovine pancreas α-trypsin (MW≈23.300 Da), ammonium
acetate, and CsI were purchased from Sigma Aldrich
(Buchs, Switzerland). Imidazole (99.5 % purity) and DMSO
were obtained from Fluka Chemie AG. Water was purified
using a Milli-Q Ultrapure water purification system by
Millipore (Barnstead, IA / USA). All MS titration experi-
ments were recorded under “native-like” conditions using
50 mM ammonium acetate buffer at pH=7.8. Stock
solutions of ligands were prepared at 40–50 mM concentra-
tion in DMSO. Prior to the measurement, the inhibitor
solutions were diluted with Milli-Q water to the desired
concentration. The protein working solution was made from a
100 μM stock solution in ammonium acetate buffer. The exact
trypsin concentration was determined using a UV spectrometer
(NanoDrop 1000; Witec AG, Littau, Switzerland).
Mass Spectrometry
ESI spectra were acquired with a hybrid quadrupole time-of-
flight mass spectrometer (Q-TOF ULTIMA; Waters/Micro-
mass, Manchester, UK) in the positive ion mode. The
instrument was controlled via the MassLynx ver. 4.0
software. In order to obtain a good signal-to-noise ratio,
100 scans were accumulated for one spectrum. The mass
spectrometer is equipped with an automated chip-based
nanoESI system (Nanomate 100; Advion Biosciences,
Ithaca, NY, USA). It has a 96-well sample plate, a rack of
96 disposable, conductive pipet tips, and a nanospray chip
containing 20×20 nozzles of 5 μm diameter. For investiga-
tion of noncovalent complexes, appropriate instrumental
conditions have to be found. In this case the desolvation
must be sufficiently complete in order to get narrow peaks
for the detected species but not to dissociate the noncovalent
complex. This can take an influence on peak broadening
because of the adduct formation with salt and buffer
molecules from the spray solution. The settings described
below were found to be a good compromise between the
intact complex detection and sufficient desolvation of
analytes. For all nanoESI-MS measurements the voltage
was set to 1.8–1.9 kV and a gentle backing pressure of 5 bar
on the spray tip was used to assist the liquid sample flow.
The source temperature was kept at 21 °C. To prevent
dissociation of the noncovalent complexes, the mass
spectrometer was run with gentle desolvation parameters.
The cone and first ion tunnel RF1 voltages, the parameters
R 
Abbr. Gly D-Ala D-Val D-Leu D-Cha 
Table 1. Chemical Structures of the Scaffold of the Investigated Benzamidine- and CMA-type Ligands. The Residues (R) Indicate the Substructure of the Inhibitor,
which Binds into the Hydrophobic S3/4 Pocket of Trypsin. This Part of the Ligand was Systematically Varied in the Size of the Hydrophobic Chain
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that control the kinetic energy of the ions in the source
region of the mass spectrometer, were optimized to 40 V and
35 V. After this stage, the ion beam passed a hexapole
collision cell filled with argon (purity 5.0; PanGas).
Collision-induced dissociation (CID) used in MS/MS experi-
ments were preformed by adjusting the acceleration collision
energy (CE) voltage until full dissociation of the parent
complex ions was achieved. Calibration of the mass
spectrometry instrument was performed using CsI clusters.
The concentration of CsI was 2 μg/uL dissolved in water/2-
propanol (1/1, vol/vol).
Data Processing
Before data processing, each mass spectrum was smoothed
(Savitzky-Gollay smooth) with the MassLynx 4.0 software
(Waters, UK). For the KD determination the measured
relative peak height intensity (I) ratios (R) of the ligand-
bound protein (P•L) to bare protein (P), R ¼ I P•Lð Þ IðPÞ= ,
were calculated for each spectrum. For this calculation, all
charge states were taken into account. The experimentally
calculated R-values were plotted versus the total inhibitor
concentration. The equation proposed by Daniel et al. [2]
was used to determine the dissociation constant (KD) from
the titration curve fit:
I P•Lð Þ
IðPÞ ¼
1
2
1 P½ 0
KD
þ L½ 0
KD
þ
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It was assumed here that the ionization efficiency for the
bare protein and the complex is equal, which allowed us to
use the intensity ratios of free protein over complex instead
of their concentrations in solution. The KD calculations and
the fitting of the titration curves were performed using
MATLAB software (2010a, The MathWorks, Natick, MA,
USA).
Kinetic Inhibition Assay
Kinetic inhibition of bovine trypsin was determined photomet-
rically at 405 nm using the chromogenic substrate Pefachrom
tPa (LoxoGmbH, Dossenheim, Germany) according to the
protocols described by Stürzebecher et al. [47] under the
following conditions: 50 mM Tris/HCl (pH 8.0), 154 mM
NaCl, 5 % DMSO, and 0.1 % polyethylene glycol (PEG) 8000
at 25 °C using different concentrations of substrate and
inhibitor. Ki values were determined at least in triplicate.
Results and Discussion
KD-Determination of the Benzamidine-Based
Inhibitors by the nanoESI-MS Titration Method
The benzamidine-based inhibitors in complex with trypsin
represent a model system for the quantification of “high-
affinity ligands.” Figure 1a provides an example of a
nanoESI mass spectrum for a solution of 5 μM trypsin in
the presence of D-Cha in 50 mM aqueous ammonium acetate
solution under nondenaturating conditions (pH=7.8). The
narrow charge state distribution, predominantly 7+, 8+, 9+,
is characteristic for native conditions, whereby 8+ is the
most intense signal. In order to determine the dissociation
constant via the titration method, a series of nanoESI
experiments were performed with increasing inhibitor con-
centrations ranging from 0.5 to 5 μM. Figure 1a–d shows
representative mass spectra obtained for the noncovalent
trypsin-D-Cha-inhibitor complex using four different ligand
concentrations. As expected, the ratio of the complex to free
protein ion signals increases with higher total inhibitor
concentration. Already at 5 μM inhibitor concentration, full
complexation is reached because the benzamidine group
binds strongly and specifically to the active site of the
enzyme and occupies the S1 pocket of trypsin. Also, the
amidinium group of benzamidine is a mimic of the
guanidinium side chain of arginine. The stabilization of the
benzamidine moiety in the S1 pocket of trypsin is based on
the a bridge linking the positively charged amidinium group
and the carboxylate group of Asp189 [35]. Three other
hydrogen bonds to Ser190, Gly210, and a conserved water
(a)
(b)
(c)
(d)
Figure 1. Representative nanoESI mass spectra of 5 μM
trypsin in the presence of the D-Cha-inhibitor obtained in
positive ion mode under “native” conditions. Trypsin (T) was
titrated with different concentrations of the D-Cha inhibitor,
(a) 0.5 μM, (b) 2 μM, (c) 2.5 μM, and (d) 5 μM. The signal for
the noncovalent complex clearly increases with increasing
amount of ligand present in solution. The full complexion is
reached at 5 μM inhibitor concentration
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molecule contribute to the strong ligand binding [35, 48,
49]. Moreover, additional van der Waals contacts between
the P1 phenyl ring and residues of the S1 pocket of trypsin
enhance the stability of the complex. The proline moiety of
the inhibitor occupies the S2 pocket [50] (Table 1).
Once the optimized conditions were found for the D-Cha-
inhibitor/trypsin complex, the protein was titrated against four
other inhibitors. Spectra obtained with trypsin and equal
concentrations (2.5 μM) of three different inhibitors (Gly, D-
Val, and D-Cha) are shown as examples in Figure 2. Based on
the length of the hydrophobic side chain, D-Cha should show
the strongest binding followed by D-Val and Gly. In other
words, at the same inhibitor concentration the highest complex
to the free protein ratio should be observed for D-Cha. The ratio
between D-Cha-trypsin and free protein ions was 2.6, while D-
Val and Gly-trypsin generated ratios of 1.6 and 0.9. The
trend in increased binding affinity of these three inhibitors
expressed by R-values is clearly confirmed by the spectra.
These different hydrophobically modified residues bind into
the hydrophobic S3/4 pocket of trypsin and are responsible
for the observed increasing affinity. This pocket is supposed
to favor binding of ligands possessing bulky aromatic
moieties [51].
The stabilizing effect of imidazole, explained in detail below,
was also tested on this particular model system. To test the
influence of imidazole, a small stabilizing solution additive, we
chose the D-Val-inhibitor. However, upon addition of 10 mM
imidazole to the nanoES solution, no change of the complex
ions to the free protein was observed (data not shown). The only
observable effect of imidazole was a shift of the charge state
distribution to lower charge states. Since the ESI titration
measurements were performed under “soft” sampling conditions
and the benzamidine inhibitors bind specifically into all trypsin
pockets, we assume that complexes are stable and not prone to
dissociation in the gas phase.
The dissociation constants KD for all trypsin-inhibitor
complexes were determined as described in the “Data
Evaluation” section. Five different titration curves for the
benzamidine-based inhibitors in complex with trypsin are
shown in Figure 3. As can be seen on the curves a larger
slope reflects a higher binding affinity and vice versa. The
KD-values based on ESI measurements and the Ki-values
measured for five different inhibitors are compared in
Table 2. KDs for binding with trypsin were in the range of
15 nM to 449 nM. The largest jump in KD value was
observed going from 79 to 15 nM, when the hydrophobic P3
side chain binding in the S3/4 pocket increased in size from
a D-Leu group to D-Cha. The comparison with inhibition
constants (Kis) was not to validate the KD values, but to see
whether they follow a similar trend as that found for the Ki
values; depending on assay conditions, KDs and Kis need
not be identical. It should also be noted that most of the Kis
for thrombin are smaller than those for trypsin. The reason is
the known preference of thrombin for inhibitors with proline
as a P2 residue, which fits perfectly below the thrombin
specific 60-insertion loop making strong hydrophobic
contacts to residues Tyr60A and Trp60D. The Ki values
for trypsin determined via the kinetic inhibition assay
increased with larger hydrophobic side chain with exception of
D-Val (Table 2). However, the kinetic inhibition constants for
D-Cha, D-Leu and D-Val are very similar and in the low
nM-range.
The discrepancy between KD and Ki values can be
easily explained by different assay conditions: for the
MS-based KD determination, ammonium acetate was used
as a buffer, while for the kinetic inhibition assay, a buffer
solution of 50 mM Tris/HCl (pH 8.0), 154 mM NaCl,
5 % DMSO, and 0.1 % polyethylene glycol (PEG) was
used. Different buffer solutions may have a substantial
influence on the binding affinities for benzamidine-trypsin
complexes. Since benzamidine inhibitors are very potent,
the Ki determination using chromogenic substrate are
close to the instrument limit of detection. The conse-
quence is that even marginal measurement inaccuracies
would have significant influence on the Ki values. This
might be a possible explanation for observing higher
binding affinity for D-Val instead of D-Cha. However,
with the exception of D-Val, the KDs and the Ki values
that were determined show that relative binding affinities
of the different inhibitors can be successfully determined,
and that the KD and Ki values decrease with larger
hydrophobic side chain.
(a)
(b)
(c)
Figure 2. Representative nanoESI-MS spectra for three
different complexes at the same inhibitor concentration
(2.5 μM). The ratio of the complex over the free protein
expressed in R-values are (a) D-Cha R=2.6; (b) D-Val R=1.6;
(c) Gly R=0.9 and confirmed the binding affinity order Gly G
D-Val G D-Cha by the spectra
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Gas Phase Stability versus Binding Affinity
Collision-induced dissociation (CID) experiments were
performed to gain additional information about the stability
of different noncovalent trypsin-inhibitor complexes in the
gas phase. For the MS/MS measurements the 8+ complex
ions were selected and dissociated during the transmission
through the mass spectrometer. The collision energy offset
was varied until the selected parent ions of different
noncovalent complexes were completely dissociated. Fig-
ure 4 shows MS/MS spectra of three different Gly-, D-Leu-,
D-Cha- ligand-trypsin complexes with a collision energy
offset of 20 V. Dissociation of the precursor ions (complex)
yielded the P7+ and P8+ ions. The extent of dissociation of
three different complexes at the same collision energy offset
is obvious in the spectra: 53 % of the D-Cha-inhibitor/
trypsin-complexes remained intact, while of the D-Leu and
Gly complexes 45 % and 34 % survive, respectively. Since
the increase in binding affinity of the different benzamidine
inhibitors is based on the differences in their hydrophobic P3
side chain, a correlation between the solution-phase binding
affinity and the gas-phase stability for D-Cha, D-Leu, and
Gly complexes could be established by a single measure-
ment.
Several groups have tried to find a correlation between
the gas-phase stability and the type of interactions involved
in a complex. As already mentioned in the Introduction, it is
important to note that the gas-phase stabilities of non-
covalent complexes generally do not correlate with solution
binding affinities.
In our work, CE50 values, the collision energy offset where
50 % of the complexes are dissociated, were used as a measure
for the gas-phase stability of the complex. The dissociation
curves for the different noncovalent complexes are shown in
Figure 5, where the normalized percentage of the intact
complex 100 I TþLð Þ I TþLð Þ þ IT
 
was plotted against the
collision energy offset. CE50-values for the five different
complexes reveal different dissociation rates during their
transmission through the mass spectrometer. While 50 % of
the D-Cha complex dissociates at a collision energy setting of
only 21 V, only 16 % of the Gly complex stays intact at the
same collision energy. The data indicate that a correlation
between the gas phase stability and the binding affinity in
solution exists, showing a general trend towards higher stability
with increasing hydrophobic P3 side chain. This correlation
between solution-phase and gas-phase stability of the com-
plexes suggests that polar and/or electrostatic contacts domi-
Figure 3. NanoESI-MS titration curves for the binding of five
different inhibitors to trypsin. The ligand concentration
ranges from 0.5 to 5 μM, while the protein concentration
was kept constant. This titration method relies on the relative
abundance of bare protein and complex ions measured by
nanoESI-MS assuming that the intensity ratio observed in the
gas phase correlates with the concentration ratio
corresponding to the free protein and complex concentration
in solution
b
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nate the noncovalent interaction, which is additionally modu-
lated by a contribution from hydrophobic contacts.
KD-Determination of the CMA series by nanoESI-MS
Titration Method
The CMA-based inhibitors serve as a model system for weak
binders in complex with trypsin. As shown in the spectra in
Figure 6a, there is no change in the charge state distribution
compared to the tighter binding benzamidine-based inhib-
itors. The +7, +8, +9 ions are predominantly observed in the
spectrum. In Figure 6a–c the mass spectra of 25 μM Gly-
inhibitor/trypsin-complex was acquired using an accumula-
tion time of 30, 60, and 180 s. We found that the relative
abundance of protonated complex ions gradually decreased
during acquisition of spectra. The longer accumulation time
led to a decrease of 90 % in the ratio of complex and bare
protein, which would result in an artificially low binding
affinity. The main reason of this observation is probably the
in-source dissociation of the complex, as suggested previ-
ously by Klassen and co-workers [21]. One way to
circumvent this limitation would be to use very short
accumulation times. However, in order to achieve better
signal-to-noise ratios in the mass spectrum, longer acquisi-
tion times are desirable. Even with the gentlest sampling
conditions, the dissociation of the trypsin-CMA-inhibitor
complexes could not be prevented. Therefore, other methods
for stabilizing protein-ligand complexes were considered. It
has recently been shown that ESI solution additives, such as
imidazole, can protect the protein-ligand complex from
dissociation.
The stabilization effect of imidazole in the presence of
25 μM Gly-inhibitor is illustrated in Figure S1 (Supporting
(a)
(b)
(c)
Figure 4. CID experiments of different noncovalent trypsin
and benzamidine based inhibitors. For the MS/MS measure-
ments the 8+-charged complex precursor ions (*) were
selected. The collision energy was set to 20 V. At the same
collision energy, the D-Cha-complex stays 53 % intact, for D-
Leu and Gly complexes 45 %, and 34 % survive
Figure 5. Normalized percentage of the intact complex
plotted against the collision energy offset. A correlation
between the gas phase stability and binding affinity is
observed: With an increasing binding affinity, more energy
is necessary to dissociate the complex
Table 2. List of Calculated Dissociation Constants (KD) for Five Benzamidine Based Ligands and Trypsin Determined by the NanoESI Titration Method, and
Ki Values from a Kinetic Inhibition Assay Determined in Solution for Trypsin and Thrombin
Benzamidine series (R) KD [nM] Ki [nM] Ki [nM]
nanoESI-MS trypsina Kinetic inhibition assay trypsinb Kinetic inhibition assay thrombinb
D-Cha 15.0±2.5 0.95±0.18 0.12±0.01
D-Leu 79.3±5.9 1.43±0.18 0.89±0.12
D-Val 87.1±15.2 0.52±0.11 1.29±0.35
D-Ala 193.5±17.8 1.95±0.77; 5±3c 5.2±0.8
Gly 449.7±75.9 16±3; 37±3 3.7±0.6
aError is based on 95 % confidence interval of the fitting curve
bThe error is given as the standard deviation calculated from at least three different measurements
cSecond independent measurement
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Information). The nanoESI measurements were acquired
under identical conditions as those in Figure 6 but now in
the presence of 10 mM imidazole in the ES-solution. Upon
its addition to the nanoES solution, nonspecific adducts
between the imidazole molecules and trypsin-ligand com-
plexes can be formed. The nonspecific interactions should be
kinetically less stable compared to specific trypsin-inhibitor
complexes. After loss of the nonspecific interactions in the
hexapole region, the internal energy of trypsin-ligand ions in
the source should be lowered, thereby stabilizing the
complex as shown in the spectra, the addition of imidazole
to Gly-inhibitor/trypsin nanoES solution results in a double
increase in the relative abundance of the complex ions. The
important effect of this small molecule is the constant
relative complex abundance measured over the longer
accumulation time (data not shown). Also, the addition of
imidazole reduces the average charge state distribution of the
Gly-inhibitor/trypsin complex from n=9–7 to n=8–6 (Figure
S1, Supporting Information). This stabilizing effect can be
explained through enhanced cooling from imidazole evapo-
ration that delays the dissociation. Coulomb repulsion can be
minimized due to the reduced net charge state of the protein
that stabilizes the complex [52]. Due to the high gas-phase
basicity of imidazole (217 kcal mol–1), it is able to strip
protons from the protonated protein ions in the gas phase
[53]. As mentioned above, this observed charge stripping
might play an important role in stabilizing of the complex,
because the lower charge states are less susceptible to
collisional dissociation. However, the appearance of the
lower charge states is probably not the main mechanism for
the complex stabilization, since SF6 provides similar
complex stabilization without any shift of charge state
distribution [27].
Another explanation for observing a drop in relative
abundance of complex ions might be due to electrochemical
reactions that occur where the electrode contacts the solution
of the ES ion source. Products of such electrochemical
reactions can alter the solution composition and affect the
relative abundance of CMA complexes in solution and
protonated complex ions during acquisition of spectra. As
already shown [54] the solution composition and the resulting
nanoESI spectra can be time dependent, with changes in the
spectra being ascribed to on-going (electro)chemical reactions
upstream in the capillary. It is conceivable that addition of
imidazole can buffer a shift of the solution phase equilibrium,
although the detailed mechanism of how this occurs is
unknown.
This observation indicates that imidazole is a suitable
additive for protecting the CMA-complexes during the
nanoES process. Because the stabilization effect of
imidazole on Gly-trypsin system appeared rather effec-
tive, we decided to perform further titration experiments
with other CMA-inhibitors in the presence of imidazole.
All titration experiments for CMA-complexes were
carried out in positive ion mode. The only difference to
the previous experiments is a higher concentration of the
ligand (1–30 μM), required to observe the weaker
interactions and to obtain useful free protein-to-complex
ratios.
The dissociation constants KD for all trypsin-inhibitor
complexes were determined by fitting the five different
titration curves as described above (data not shown). The
results, given in Table 3, show higher dissociation constants
compared to the benzamidine series, with KD values
between 2.9 and 17.6 μM, some 1–2 orders of magnitude
lower than the benzamidine complexes. The reason for lower
(a)
(b)
(c)
Figure 6. Representative nanoESI-MS spectra for 25 μM
Gly-inhibitor in complex with trypsin. The ratio (R) between
complex and bare protein decreases with increasing accu-
mulation time after (a) 30 s (R=0.4); (b) 60 s (R=0.26); (c)
180 s (R=0.21)
Table 3. List of Calculated Dissociation Constants (KD) for Five CMA
Based Ligands Determined by the NanoESI Titration Method and Kinetic
Inhibition Assay (Ki) Determined in Solution. For Both Methods the
Binding Affinity Increasing in Order Gly G D-Ala G D-Leu
CMA series (R) KD [μM] Ki [μM] Ki [nM]
nanoESI-MS
trypsina
Kinetic inhibition
assay trypsinb
Kinetic inhibition
assay thrombinb
D-Cha 17.63±1.2 6.6±0.8 0.052±0.005
D-Leu 2.9±0.2 0.4±0.09 0.259±0.024
D-Val 12.4±0.2 6±0.2 0.788±0.070
D-Ala 8.4±1.4 3.1±1 2.2±0.4
Gly 24.4±0.49 9.9±0.1 1.5±0.1
aError is based on 95 % confidence interval of the fitting curve
bThe error is given as the standard deviation calculated from at least three
different measurements
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binding affinity compared to the previously described
benzamidine based inhibitors is the substitution by the
CMA anchor group, which is involved in the binding to
the S1 pocket of trypsin. Moreover, unlike as for the
benzamidine complexes, no trend in KD with increasing side-
chain could be observed. However, an increased binding
affinity is clearly observed in the order Gly G D-Ala G D-Leu
(Table 3). Since the X-ray data for these complexes are not
available, we assume that the different trend of binding
affinities is probably due to the different anchor groups of the
different ligand series.
The relative difference in the KD values determined
by nanoESI-MS and the characterized Ki values are
equivalent, considering the error margins of the methods.
These results confirm the same trend observed in the
kinetic inhibition assay as under the experimental MS
conditions, demonstrating the ability of quantitative ESI-
MS measurement to clearly distinguish between ligand
affinities.
Conclusions
In conclusion, we have applied nanoESI-MS for the
investigation of a series of hydrophobically modified
ligands interacting with trypsin. The size of the hydro-
phobic side chain (R) that binds in the S3/4 pocket of
trypsin was systematically increased. The different sub-
stituents (R = Gly, D-Ala, D-Val, D-Leu, D-Cha) have a
significant influence on the binding constants. The
quantification of binding affinities was possible using
the titration method. In the case of the benzamidine
series the trend to higher binding affinity with increasing
hydrophobic P3 side chain is strong, ranging from
450 nM to 15 nM. The binding affinities measured by
ESI-MS titration and kinetic inhibition constants for the
benzamidine-trypsin complexes show, with the exception
of D-Val, the same relative ordering. Collision-induced
dissociation experiments across the benzamidene type series
clearly show the correlation between the binding affinity and
the gas phase stability. More collision energy is necessary to
dissociate the complex with higher binding affinity and vice
versa.
The CMA-inhibitors served as a model system for a
series of less potent complexes, which are prone to in-
source dissociation. This effect causes a reduced relative
abundance of the gaseous complex ions and leads
therefore to artificially lower binding affinities in the
measurements. Upon addition of imidazole, a stabilizing
solution additive, the relative abundance of the non-
dissociated could be increased. Compared to benzami-
dine-inhibitors the CMA ligands did not show the clear
trend towards higher binding strengths with longer side-
chains. The increased binding affinity is observed for
Gly G D-Ala G D-Leu.
For the CMA series the relative difference for KD and the
characterized Ki values are equivalent, which demonstrates
the ability of quantitative ESI-MS to distinguish between
ligand affinities.
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